117 related articles for article (PubMed ID: 20585878)
1. Clinical outcomes and prognostic factors of metastatic gastric carcinoma patients who experience gastrointestinal perforation during palliative chemotherapy.
Kang MH; Kim SN; Kim NK; Park YI; Kim YW; Ryu KW; Lee JH; Lee JS; Park SR
Ann Surg Oncol; 2010 Dec; 17(12):3163-72. PubMed ID: 20585878
[TBL] [Abstract][Full Text] [Related]
2. [Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer].
Dong NN; Wang MY; Zhang Q; Liu ZF
Ai Zheng; 2009 Apr; 28(4):412-5. PubMed ID: 19622303
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome of gastric cancer patients with bone marrow metastases.
Kim HS; Yi SY; Jun HJ; Lee J; Park JO; Park YS; Jang J; Kim HJ; Ko Y; Lim HY; Kang WK
Oncology; 2007; 73(3-4):192-7. PubMed ID: 18418012
[TBL] [Abstract][Full Text] [Related]
4. [Multiple Sister Mary Joseph's nodules in a patient with gastric cancer].
Ehmann LM; Fiegl M; Wollenberg A
Dtsch Med Wochenschr; 2011 Jun; 136(25-26):1365-8. PubMed ID: 21674424
[TBL] [Abstract][Full Text] [Related]
5. Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer.
Yano M; Yasuda T; Fujiwara Y; Takiguchi S; Miyata H; Monden M
J Surg Oncol; 2004 Oct; 88(1):39-43. PubMed ID: 15384086
[TBL] [Abstract][Full Text] [Related]
6. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
[TBL] [Abstract][Full Text] [Related]
7. [A case of gastric cancer with umbilical metastasis that responded to TS-1 with low-dose cis-platinum].
Takashima T; Yamagata S; Fukunaga S; Inoue T; Yashiro M; Nakata B; Nishiguchi Y; Kato Y; Ohira M; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2004 Feb; 31(2):247-50. PubMed ID: 14997761
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Idelevich E; Karminsky N; Dinerman M; Katsenelson RL; Zvi NB; Baruch NB; Biran H; Man S; Shani A
Acta Oncol; 2007; 46(3):324-9. PubMed ID: 17450467
[TBL] [Abstract][Full Text] [Related]
9. A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.
Kanagavel D; Pokataev IA; Fedyanin MY; Tryakin AA; Bazin IS; Narimanov MN; Yakovleva ES; Garin AM; Tjulandin SA
Ann Oncol; 2010 Sep; 21(9):1779-1785. PubMed ID: 20150573
[TBL] [Abstract][Full Text] [Related]
10. [Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1].
Suzuki T; Iwabuchi M; Matsuda Y; Imai G; Yokoyama H; Mochida A; Takahashi H; Shiina M; Yamada K; Ishibashi J; Suzuki S; Chida N; Tadokoro K
Gan To Kagaku Ryoho; 2003 Jan; 30(1):133-9. PubMed ID: 12557719
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study.
Inal A; Kaplan MA; Kuçukoner M; Urakci Z; Guven M; Nas N; Yunce M; Işikdogan A
Asian Pac J Cancer Prev; 2012; 13(8):3869-72. PubMed ID: 23098485
[TBL] [Abstract][Full Text] [Related]
12. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
[TBL] [Abstract][Full Text] [Related]
13. Pathological complete response induced by the combination therapy of S-1 and 24-h infusion of cisplatin in two cases initially diagnosed as inoperable advanced gastric cancer.
Ina K; Kataoka T; Takeuchi Y; Fukuoka T; Miwa T; Nishio T; Furuta R; Masaki A; Mori F; Kayukawa S; Nagao S; Ando T; Goto H
Oncol Rep; 2008 Aug; 20(2):259-64. PubMed ID: 18636184
[TBL] [Abstract][Full Text] [Related]
14. [A case of long survival with UFT and lentinan treatment in a patient with peritoneal metastasis of gastric carcinoma].
Nakayama H; Aoki N; Hayashi S; Wakabayashi K; Karube H; Ogame H; Aoki H; Sakamoto N; Masuda H; Hemmi A
Gan To Kagaku Ryoho; 2004 Feb; 31(2):241-3. PubMed ID: 14997760
[TBL] [Abstract][Full Text] [Related]
15. [Results of intraperitoneal active charcoal-mitomycin C therapy of stomach carcinoma with serosa invasion].
Fass J; Jansen M; Zengel K; Reinecke T; Asshoff G; Schumpelick V
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1363-6. PubMed ID: 9931883
[TBL] [Abstract][Full Text] [Related]
16. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric carcinoma undergoing potentially curative resection.
Lorenzen S; Panzram B; Rosenberg R; Nekarda H; Becker K; Schenk U; Höfler H; Siewert JR; Jäger D; Ott K
Ann Surg Oncol; 2010 Oct; 17(10):2733-9. PubMed ID: 20490698
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy for peritoneal dissemination in gastric cancer under ureteral catheterization].
Kubo Y; Kurita A; Saeki T; Yokoyama N; Tanada M; Takiyama W; Saeki H; Takashima S
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1951-7. PubMed ID: 8978803
[TBL] [Abstract][Full Text] [Related]
19. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
[TBL] [Abstract][Full Text] [Related]
20. Sister Mary Joseph's nodule as the sole presenting sign of gastric signet ring cell adenocarcinoma.
Ioannidis O; Cheva A; Stavrakis T; Paraskevas G; Papadimitriou N; Kakoutis E; Makrantonakis A
Gastroenterol Clin Biol; 2010 Oct; 34(10):565-8. PubMed ID: 20739130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
